GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cue Health Inc (OTCPK:HLTHQ) » Definitions » ROE %

HLTHQ (Cue Health) ROE % : -185.81% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Cue Health ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Cue Health's annualized net income for the quarter that ended in Dec. 2023 was $-593.73 Mil. Cue Health's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was $319.54 Mil. Therefore, Cue Health's annualized ROE % for the quarter that ended in Dec. 2023 was -185.81%.

The historical rank and industry rank for Cue Health's ROE % or its related term are showing as below:

HLTHQ' s ROE % Range Over the Past 10 Years
Min: -93.53   Med: -30.24   Max: 28.55
Current: -93.53

During the past 5 years, Cue Health's highest ROE % was 28.55%. The lowest was -93.53%. And the median was -30.24%.

HLTHQ's ROE % is ranked worse than
91.84% of 625 companies
in the Healthcare Providers & Services industry
Industry Median: 4.7 vs HLTHQ: -93.53

Cue Health ROE % Historical Data

The historical data trend for Cue Health's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cue Health ROE % Chart

Cue Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
- - 28.55 -30.24 -90.35

Cue Health Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -70.27 -73.00 -46.28 -185.81 -88.08

Competitive Comparison of Cue Health's ROE %

For the Health Information Services subindustry, Cue Health's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cue Health's ROE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cue Health's ROE % distribution charts can be found below:

* The bar in red indicates where Cue Health's ROE % falls into.



Cue Health ROE % Calculation

Cue Health's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=-373.464/( (576.494+250.252)/ 2 )
=-373.464/413.373
=-90.35 %

Cue Health's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Sep. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=-593.728/( (388.834+250.252)/ 2 )
=-593.728/319.543
=-185.81 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


Cue Health  (OTCPK:HLTHQ) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-593.728/319.543
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-593.728 / 69.524)*(69.524 / 416.04)*(416.04 / 319.543)
=Net Margin %*Asset Turnover*Equity Multiplier
=-853.99 %*0.1671*1.302
=ROA %*Equity Multiplier
=-142.7 %*1.302
=-185.81 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-593.728/319.543
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-593.728 / -593.488) * (-593.488 / -261.136) * (-261.136 / 69.524) * (69.524 / 416.04) * (416.04 / 319.543)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1.0004 * 2.2727 * -375.61 % * 0.1671 * 1.302
=-185.81 %

Note: The net income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Cue Health ROE % Related Terms

Thank you for viewing the detailed overview of Cue Health's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cue Health Business Description

Traded in Other Exchanges
N/A
Address
4980 Carroll Canyon Road, Suite 100, San Diego, CA, USA, 92121
Cue Health Inc is a health technology company. It puts consumers in control of health information and places diagnostic information at the center of care. It enables people to manage their health through real-time, actionable and connected health data. Further, it offers individuals, enterprises, government agencies, and healthcare providers access to lab-quality diagnostic testing at home, at work, or at the point of care, all in a device that fits in the palm of hand. Its Cue Integrated Care Platform consists of multiple hardware, software, and diagnostic components and has been engineered so that it can be directly integrated into existing workflows and on-demand services, such as telemedicine, e-Rx services, and EMR systems.
Executives
T-twelve Holdings, Llc 10 percent owner C/O SIERRA FIDUCIARY SUPPORT SERVICES, 100 WEST LIBERTY ST., SUITE 750, RENO NV 89501
Tup Investments, L.p. 10 percent owner 520 NEWPORT CENTER DR., 21ST FLOOR, NEWPORT BEACH CA 92660
Tarsadia Investments, Llc 10 percent owner 520 NEWPORT CENTER DR., 21ST FLOOR, NEWPORT BEACH CA 92660
Cp (hlth), Llc 10 percent owner 520 NEWPORT CENTER DR., 21ST FLOOR, NEWPORT BEACH CA 92660
Tfc Manager, Llc 10 percent owner C/O SIERRA FIDUCIARY SUPPORT SERVICES, 100 WEST LIBERTY ST., SUITE 750, RENO NV 89501
Nvga I, Llc 10 percent owner 520 NEWPORT CENTER DR., 21ST FLOOR, NEWPORT BEACH CA 92660
Tccs I, Lp 10 percent owner 10 EAST 53RD STREET, 23RD FLOOR, NEW YORK NY 10022
Tc Gp, Llc 10 percent owner 10 EAST 53RD STREET, 23RD FLOOR, NEW YORK NY 10022
Tarsadia Capital, Llc 10 percent owner 10 EAST 53RD STREET, 23RD FLOOR, NEW YORK NY 10022
Aasim Javed officer: Chief Financial Officer C/O CUE HEALTH INC, 4980 CARROLL CANYON RD SUITE 100, SAN DIEGO CA 92121
Randall E. Pollard officer: Chief Accounting Officer 6229 PINE TREE CT., LONG GROVE IL 60047
Clint Sever officer: Chief Product Officer C/O CUE HEALTH INC., 4980 CARROLL CANYON RD. SUITE 100, SAN DIEGO CA 92121
Sachin H. Jain director C/O CARDIOVASCULAR SYSTEMS, INC., 1225 OLD HIGHWAY 8 NW, ST. PAUL MN 55112
Joshua Ghaim director C/O CUE HEALTH INC., 4980 CARROLL CANYON ROAD SUITE 100, SAN DIEGO CA 92121
Kelly P. Day 10 percent owner 865 FIGUEROA STREET, SUITE 700, LOS ANGELES CA 90017